Literature DB >> 10639448

Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae.

D E Briles1, E Ades, J C Paton, J S Sampson, G M Carlone, R C Huebner, A Virolainen, E Swiatlo, S K Hollingshead.   

Abstract

Acquisition of pneumococci is generally from carriers rather than from infected individuals. Therefore, to induce herd immunity against Streptococcus pneumoniae it will be necessary to elicit protection against carriage. Capsular polysaccharide-protein conjugates, PspA, and PsaA are known to elicit some protection against nasopharyngeal carriage of pneumococci but do not always completely eliminate carriage. In this study, we observed that PsaA elicited better protection than did PspA against carriage. Pneumolysin elicited no protection against carriage. Immunization with a mixture of PsaA and PspA elicited the best protection against carriage. These results indicate that PspA and PsaA may be useful for the elicitation of herd immunity in humans. As PspA and pneumolysin are known to elicit immunity to bacteremia and pneumonia, their inclusion in a mucosal vaccine may enable such a vaccine to prevent invasive disease as well as carriage.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10639448      PMCID: PMC97207          DOI: 10.1128/IAI.68.2.796-800.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  38 in total

1.  The effect of Streptococcus pneumoniae pneumolysin on human respiratory epithelium in vitro.

Authors:  C Feldman; T J Mitchell; P W Andrew; G J Boulnois; R C Read; H C Todd; P J Cole; R Wilson
Journal:  Microb Pathog       Date:  1990-10       Impact factor: 3.738

2.  Distribution, persistence, and recall of serum and salivary antibody responses to peroral immunization with protein antigen I/II of Streptococcus mutans coupled to the cholera toxin B subunit.

Authors:  M W Russell; H Y Wu
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

3.  Carriage of pneumococci after pneumococcal vaccination.

Authors:  S K Obaro; R A Adegbola; W A Banya; B M Greenwood
Journal:  Lancet       Date:  1996-07-27       Impact factor: 79.321

Review 4.  The contribution of pneumolysin to the pathogenicity of Streptococcus pneumoniae.

Authors:  J C Paton
Journal:  Trends Microbiol       Date:  1996-03       Impact factor: 17.079

5.  Immunization of mice with pneumolysin toxoid confers a significant degree of protection against at least nine serotypes of Streptococcus pneumoniae.

Authors:  J E Alexander; R A Lock; C C Peeters; J T Poolman; P W Andrew; T J Mitchell; D Hansman; J C Paton
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

6.  Protection of mice against fatal pneumococcal challenge by immunization with pneumococcal surface adhesin A (PsaA).

Authors:  D F Talkington; B G Brown; J A Tharpe; A Koenig; H Russell
Journal:  Microb Pathog       Date:  1996-07       Impact factor: 3.738

7.  PspA, a protection-eliciting pneumococcal protein: immunogenicity of isolated native PspA in mice.

Authors:  D E Briles; J D King; M A Gray; L S McDaniel; E Swiatlo; K A Benton
Journal:  Vaccine       Date:  1996-06       Impact factor: 3.641

8.  PspA, a surface protein of Streptococcus pneumoniae, is capable of eliciting protection against pneumococci of more than one capsular type.

Authors:  L S McDaniel; J S Sheffield; P Delucchi; D E Briles
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

9.  Truncated Streptococcus pneumoniae PspA molecules elicit cross-protective immunity against pneumococcal challenge in mice.

Authors:  R C Tart; L S McDaniel; B A Ralph; D E Briles
Journal:  J Infect Dis       Date:  1996-02       Impact factor: 5.226

10.  Use of insertional inactivation to facilitate studies of biological properties of pneumococcal surface protein A (PspA).

Authors:  L S McDaniel; J Yother; M Vijayakumar; L McGarry; W R Guild; D E Briles
Journal:  J Exp Med       Date:  1987-02-01       Impact factor: 14.307

View more
  117 in total

1.  Inhibition of pneumococcal adherence to human nasopharyngeal epithelial cells by anti-PsaA antibodies.

Authors:  Sandra Romero-Steiner; Tamar Pilishvili; Jacquelyn S Sampson; Scott E Johnson; Annie Stinson; George M Carlone; Edwin W Ades
Journal:  Clin Diagn Lab Immunol       Date:  2003-03

2.  Pneumococcal 6-phosphogluconate-dehydrogenase, a putative adhesin, induces protective immune response in mice.

Authors:  D Daniely; M Portnoi; M Shagan; A Porgador; N Givon-Lavi; E Ling; R Dagan; Y Mizrachi Nebenzahl
Journal:  Clin Exp Immunol       Date:  2006-05       Impact factor: 4.330

3.  Involvement of Lsp, a member of the LraI-lipoprotein family in Streptococcus pyogenes, in eukaryotic cell adhesion and internalization.

Authors:  Andrea Elsner; Bernd Kreikemeyer; Andrea Braun-Kiewnick; Barbara Spellerberg; Bettina A Buttaro; Andreas Podbielski
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

4.  PspA protects Streptococcus pneumoniae from killing by apolactoferrin, and antibody to PspA enhances killing of pneumococci by apolactoferrin [corrected].

Authors:  Mirza Shaper; Susan K Hollingshead; William H Benjamin; David E Briles
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

Review 5.  Mucosal immunology of vaccines against pathogenic nasopharyngeal bacteria.

Authors:  Q Zhang; A Finn
Journal:  J Clin Pathol       Date:  2004-10       Impact factor: 3.411

Review 6.  Serotype-independent pneumococcal experimental vaccines that induce cellular as well as humoral immunity.

Authors:  Richard Malley; Porter W Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-02       Impact factor: 11.205

Review 7.  A review on anti-adhesion therapies of bacterial diseases.

Authors:  Arezoo Asadi; Shabnam Razavi; Malihe Talebi; Mehrdad Gholami
Journal:  Infection       Date:  2018-10-01       Impact factor: 3.553

8.  Limited role of antibody in clearance of Streptococcus pneumoniae in a murine model of colonization.

Authors:  Tera L McCool; Jeffrey N Weiser
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

Review 9.  Animal models of Streptococcus pneumoniae disease.

Authors:  Damiana Chiavolini; Gianni Pozzi; Susanna Ricci
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

10.  Immunization of mice with single PspA fragments induces antibodies capable of mediating complement deposition on different pneumococcal strains and cross-protection.

Authors:  Adriana T Moreno; Maria Leonor S Oliveira; Daniela M Ferreira; Paulo L Ho; Michelle Darrieux; Luciana C C Leite; Jorge M C Ferreira; Fabiana C Pimenta; Ana Lúcia S S Andrade; Eliane N Miyaji
Journal:  Clin Vaccine Immunol       Date:  2010-01-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.